Table 1.
Participant characteristics.
| Individuals post-stroke(n = 25) | CON(n = 25) | p-value | |
|---|---|---|---|
| Age (years) | 60 ± 12 | 60 ± 13 | 0.92 |
| Female n (%) | 9 (36%) | 9 (36%) | 1.00 |
| BMI (kg/m2) | 30.6 ± 5.8 | 28.6 ± 6.6 | 0.27 |
| Race n (%) | 0.54 | ||
| Asian | 0 | 1 | |
| Black/African American | 4 | 2 | |
| White/Caucasian | 20 | 22 | |
| White & Native American | 1 | 0 | |
| Beta-blocker medication n (%) | 10 (40%) | 1 (4%) | 0.01 a |
| Statin medication n (%) | 22 (88%) | 11 (44%) | 0.002 a |
| Carotid stenosis n (%) | 0.67 | ||
| Normal | 23 (92%) | 21 (84%) | |
| <50% | 2 (8%) | 4 (16%) | |
| Carotid-femoral pulse wave velocity (m/s) b | 9.18 ± 1.86 | 8.00 ± 1.89 | 0.01 a |
| TBRS estimatedV̇O2max (ml·kg−1·min−1) | 29.5 ± 9.1 | 32.3 ± 10.0 | 0.32 |
| Absolute high-intensity (Watts) b | 80 ± 27 | 116 ± 35 | 0.001 a |
| Absolute active recovery (Watts) b | 16 ± 2 | 18 ± 4 | 0.04 a |
| Rating of perceived exertion (6–20) b | 14 ± 2 | 14 ± 2 | 0.73 |
| Stroke characteristics | |||
| Months post-stroke | 31 ± 16 | ||
| Type of Stroken, % (ischemic, hemorrhagic) | 19 (76%), 6 (24%) | ||
| Stroke Location n (%) | |||
| MCA & Territories | 10 (40%) | ||
| ACA & Territories | 3 (12%) | ||
| PCA & Territories | 6 (24%) | ||
| Vertebrobasilar | 2 (8%) | ||
| Cerebellar | 1 (4%) | ||
| Combined MCA & ACA | 3 (12%) | ||
Means ± SD. BMI: body mass index; TBRS: total body recumbent stepper; V̇O2max: maximal oxygen consumption.
a
Significant between groups.
b
Not normally distributed, used Mann-Whitney U test.